Methylphenidate is classified as a “specific substance” on the World Anti-Doping Agency Prohibited List, banned in-competition. Under the rules of the Canadian Anti-Doping Program (CADP), an athlete facing a first violation involving a “specified substance” can seek to have the sanction reduced to a reprimand. Based on factors assessed, including the athlete’s degree of fault, the CCES proposed a sanction of a reprimand and no period of ineligibility.
In response to the CCES’ notification of the adverse analytical finding, Ms. Woodhouse waived her right to a hearing, acknowledged the anti-doping rule violation, and accepted the sanction of a reprimand proposed by the CCES.
In compliance with rule 7.10 of the CADP, a copy of the CCES’ file outcome summary can be found at: http://cces.ca/wp-content/uploads/files/content/docs/pdf/cces-case-fileoutcomesummary-3908884-e.pdf.
The CCES is an independent, national, not-for profit organization with a responsibility to administer the CADP. Under the CADP rules, the CCES announces publicly every anti-doping rule violation. We recognize that true sport can make a great difference for individuals, communities and our country. We are committed to working collaboratively to activate a values-based and principle-driven sport system; protecting the integrity of sport from the negative forces of doping and other unethical threats; and advocating for sport that is fair, safe and open to everyone.
— 30 —